Unicycive Therapeutics, Inc.
NASDAQ:UNCY
0.4347 (USD) • At close October 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|
Operating Activities: | ||||||
Net Income
| -30.544 | -18.058 | -10.017 | -2.264 | -2.165 | -1.12 |
Depreciation & Amortization
| 0.284 | 0.161 | 0.013 | 0 | 0 | 0 |
Deferred Income Tax
| -1.276 | 0 | 0.127 | 0 | 0 | 0 |
Stock Based Compensation
| 1.767 | 1.047 | 0.966 | 0.232 | 0.024 | 0 |
Change In Working Capital
| -0.093 | 1.178 | -0.105 | -0.166 | 0.305 | 0.006 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| 1.276 | 1.267 | 1.241 | -0.068 | 0.308 | 0.031 |
Other Working Capital
| -1.369 | -0.089 | -1.346 | -0.098 | -0.003 | -0.025 |
Other Non Cash Items
| 11.579 | 0.021 | 3.249 | 0.739 | 0.66 | 0.308 |
Operating Cash Flow
| -18.283 | -15.651 | -5.767 | -1.459 | -1.176 | -0.775 |
Investing Activities: | ||||||
Investments In Property Plant And Equipment
| -0.012 | -0.002 | -0.029 | 0 | 0 | 0 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 |
Investing Cash Flow
| -0.012 | -0.002 | -0.029 | 0 | 0 | 0 |
Financing Activities: | ||||||
Debt Repayment
| 0 | 0 | -0.015 | -0.16 | -0.009 | -0.55 |
Common Stock Issued
| 28.037 | 0.011 | 22.39 | 0.141 | 1.166 | 0.25 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| -0.867 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 27.541 | -0.482 | 22.375 | 1.463 | 0.009 | 0.8 |
Financing Cash Flow
| 27.541 | -0.471 | 22.375 | 1.444 | 1.166 | 0.8 |
Other Information: | ||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| 9.246 | -16.124 | 16.579 | -0.015 | -0.01 | 0.025 |
Cash At End Of Period
| 9.701 | 0.455 | 16.579 | 0 | 0.015 | 0.025 |